Celularity looks to advance cellular therapies with Palantir

Celularity looks to advance cellular therapies with Palantir
Celularity looks to advance cellular therapies with Palantir

Dr. Robert Hariri, Celularity CEO, joins Yahoo Finance’s Alexis Christoforous to discuss Celularity’s partnership with Palantir and the outlook for cellular medicine.

Previous articleJPM Expected To Post A $30.49B Worth Of Sales For The Quarter
Next articleTechnovation is a global competition that gives girls an opportunity to solve real world problems